blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2850434

EP2850434 - TUMOR CELL ISOLATION/PURIFICATION PROCESS AND METHODS FOR USE THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.12.2016
Database last updated on 23.04.2024
Most recent event   Tooltip16.12.2016Application deemed to be withdrawnpublished on 18.01.2017  [2017/03]
Applicant(s)For all designated states
Diatech Oncology LLC
9208 Heritage Dr.
Brentwood, Tennessee 37027 / US
[2015/13]
Inventor(s)01 / PRESANT, Cary
2345 Cumberland Road
San Marino, CA 91108 / US
02 / PERREE, Mathieu
1620 Holy Cross Street
Montreal H4E 2A1 / CA
03 / HALLQUIST, Allan
13351 Rosehawk Drive
Morning View, KY 41063 / US
 [2015/13]
Representative(s)Hally, Anna-Louise
FRKelly
27 Clyde Road
Dublin D04 F838 / IE
[N/P]
Former [2015/13]Hally, Anna-Louise
FRKelly
27 Clyde Road
Dublin 4 / IE
Application number, filing date13790721.814.03.2013
WO2013US31300
Priority number, dateUS201261647248P15.05.2012         Original published format: US 201261647248 P
[2015/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013172955
Date:21.11.2013
Language:EN
[2013/47]
Type: A1 Application with search report 
No.:EP2850434
Date:25.03.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 21.11.2013 takes the place of the publication of the European patent application.
[2015/13]
Search report(s)International search report - published on:KR21.11.2013
(Supplementary) European search report - dispatched on:EP11.12.2015
ClassificationIPC:G01N33/50, G01N33/557
[2016/02]
CPC:
G01N33/5011 (EP,CN,KR,US); C12N5/0693 (CN,KR,US); C12Q1/24 (KR);
G01N33/15 (KR); G01N33/52 (KR); G01N33/557 (EP,CN,KR,US);
G01N33/574 (KR); C12N2527/00 (US); G01N2500/04 (US);
G01N2500/10 (CN,US) (-)
Former IPC [2015/13]G01N33/574, G01N33/15, C12N5/07
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/13]
TitleGerman:TUMORZELLENISOLIERUNGS-/-REINIGUNGSVERFAHREN UND VERFAHREN ZUR VERWENDUNG DAVON[2015/13]
English:TUMOR CELL ISOLATION/PURIFICATION PROCESS AND METHODS FOR USE THEREOF[2015/13]
French:PROCÉDÉ D'ISOLEMENT/PURIFICATION DE CELLULES TUMORALES ET LEURS PROCÉDÉS D'UTILISATION[2015/13]
Entry into regional phase15.12.2014National basic fee paid 
15.12.2014Search fee paid 
15.12.2014Designation fee(s) paid 
15.12.2014Examination fee paid 
Examination procedure15.12.2014Examination requested  [2015/13]
16.07.2015Amendment by applicant (claims and/or description)
16.07.2016Application deemed to be withdrawn, date of legal effect  [2017/03]
26.08.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/03]
Fees paidRenewal fee
31.03.2015Renewal fee patent year 03
31.03.2016Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO0240702  (UNIV VANDERBILT [US]) [A] 1-15* the whole document *;
 [Y]US2011244503  (PERREE MATHIEU [CA], et al) [Y] 3-6,8,9,11 * whole document, in particular example 2; claim 10 *;
 [XY]  - KAREN S. BALLARD ET AL, "Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment", JOURNAL OF GYNECOLOGIC ONCOLOGY, (20100101), vol. 21, no. 1, doi:10.3802/jgo.2010.21.1.45, ISSN 2005-0380, page 45, XP055173007 [X] 1,2,7,10,12-15 * whole document, in particular p. 46, col. 1, par. 1p. 48, col. 1, par. 1; p. 49, col. 1, par. 1; table 2-5 * [Y] 1-15

DOI:   http://dx.doi.org/10.3802/jgo.2010.21.1.45
 [Y]  - KRAVTSOV ET AL, "Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, (19980801), vol. 92, no. 3, ISSN 0006-4971, pages 968 - 980, XP002118802 [Y] 1-15 * whole document, in particular p. 971, col. 1, par. 1 - col. 2, par. par. 2 *
 [A]  - KRAVTSOV ET AL, "A novel microculture kinetic assay (MiCK assay) for malignant cell growth and chemosensitivity", EUROPEAN JOURNAL OF CANCER, PERGAMON, GB, vol. 30, no. 10, doi:10.1016/0959-8049(94)00291-C, ISSN 0959-8049, (19940101), pages 1564 - 1570, (19940101), XP026212498 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/0959-8049(94)00291-C
International search[A]US6258553  (KRAVTSOV VLADIMIR D [US]);
 [A]KR100721927B  (ISU ABXIS CO LTD [KR]);
 [A]US2011244503  (PERREE MATHIEU [CA], et al);
 [X]  - BALLARD ET AL., "Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment", JOURNAL OF GYNECOLOGIC ONCOLOGY, (201003), vol. 21, no. 1, pages 45 - 49, XP055173007

DOI:   http://dx.doi.org/10.3802/jgo.2010.21.1.45
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.